SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling

BACKGROUND: Overexpression of epidermal growth factor receptor (EGFR) occurs in approximately 90% of head and neck squamous cell carcinoma (HNSCC), and is correlated with poor prognosis. Thus, targeting EGFR is a promising strategy for treatment of HNSCC. Several small molecule EGFR inhibitors have...

Descripción completa

Detalles Bibliográficos
Autores principales: Barzegar, Mansoureh, Ma, Shuang, Zhang, Chao, Chen, Xin, Gu, Ying, Shang, Chaowei, Jiang, Xiaojuan, Yang, Jiao, Nathan, Cherie-Ann, Yang, Shengyong, Huang, Shile
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674107/
https://www.ncbi.nlm.nih.gov/pubmed/28873083
http://dx.doi.org/10.1038/bjc.2017.298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674107/
https://www.ncbi.nlm.nih.gov/pubmed/28873083
http://dx.doi.org/10.1038/bjc.2017.298

Ejemplares similares